Abstract
Background Cognitive impairment is projected to rise substantially by 2050, particularly in low- and middle-income countries with aging populations. Reproductive life history may be associated with later-life cognitive function. We aim to estimate the association between number of children and mid- to later-life cognitive performance.
Method Data were from 5059 older adults (46% men) aged ≥40 years in the population-representative rural cohort of the “Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa” (HAALSI). We fit linear regression and modified Poisson models to estimate the associations between number of children and cognitive function. Analyses were stratified by sex/gender, controlling for age, education, literacy, self-reported childhood health, country of birth, and father’s occupation.
Results After adjustment, men with any number of children and women with 5+ children had higher cognitive function compared to those without children (β[95% CI]: Men: 1-2: 0.29[0.13 – 0.45], 3-4: 0.50[0.34 – 0.65], 5+: 0.48[0.33 – 0.63]; Women: 5+: 0.17[0.01 – 0.34]). Results from the adjusted modified Poisson regression models found that for men and women, groups with any number of children showed a lower prevalence of cognitive impairment than the group with 0 children (PR[95% CI] Men: 1-2: 0.48[0.31 – 0.75], 3-4: 0.21[0.12 – 0.37], 5+: 0.28[0.19 – 0.41], Women: 1-2: 0.52[0.31 – 0.88], 3-4: 0.55[0.33 – 0.91], 5+: 0.41[0.25 – 0.69]).
Conclusion Among older rural South African adults, having children was associated with greater cognitive performance and lower prevalence of cognitive impairment. Men tended to have larger protective associations than women, which may be due to sex/gender differences in biological and social roles of childbearing and rearing. Understanding the complex relationship between having children and later-life cognitive function may help identify interventions to reduce the impact of cognitive decline.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Institute on Aging of the National Institutes of Health (grant number R01AG069128). The HAALSI study was funded by the NIA of the NIH (P01 AG041710). HAALSI is nested within the Agincourt Health and socio-Demographic Surveillance System, with funding from The Wellcome Trust (058893/Z/99/A; 069683/Z/02/Z; 085477/ Z/08/Z; 085477/B/08/Z), University of the Witwatersrand, and Medical Research Council, South Africa.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Researchers obtained written, informed consent from all participants in the local language, xiTsonga, or English. If a participant was not literate, a witness was present, and the participant provided a fingerprint instead of a signature. Researchers obtained ethical approvals for the study from the University of the Witwatersrand Human Research Ethics Committee (Medical) (ref. M141159), the Harvard T.H. Chan School of Public Health, Office of Human Research Administration (ref. C13-1608-02), and the Mpumalanga Provincial Research and Ethics Committee. Indiana University Bloomington deemed this secondary data analysis on deidentified data "Not Human Subjects Research" (ref. 16421).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability Statement
The datasets analyzed for this study can be accessed at the following link: https://haalsi.org/data.
